期刊文献+

治疗性ERCP术后相关并发症的防治 被引量:32

Prevention and treatment of complications of therapeutic endoscopic retrograde cholangiopancreatography
原文传递
导出
摘要 目的探讨经内镜逆行胰胆管造影(ERCP)术后相关并发症的发生原因、临床表现、治疗方法及效果。方法对2003年5月—2008年12月施行的4 810例ERCP患者的临床资料进行回顾性分析。结果 4 810例ERCP中,共发生并发症245例(5.1%),其中急性胰腺炎113例(2.3%),急性胆管炎76例(1.6%),消化道出血33例(0.7%),十二指肠穿孔4例(0.1%),败血症及脓毒败血症19例(0.4%)。死亡2例(0.04%),1例为EST术后十二指肠穿孔,全身多器官功能衰竭死亡;另1例为ERCP术后发生毛细胆管炎,肝功能衰竭死亡。反复多次胰管显影是ERCP术后发生急性胰腺炎的最主要原因,胆道梗阻因素的存在导致胆道引流不畅是发生胆道感染、败血症等的重要因素,十二指肠穿孔发生率不高但后果严重,需及时积极处理。结论严格掌握ERCP及EST的适应证和禁忌证,掌握娴熟的操作技巧,造影后保持胆道引流通畅并严密观察病情变化,可以减少并发症的发生,提高治疗性ERCP的安全性。 Objective To investigate the causes,clinical manifestation,treatment and therapeutic effect of the complications of therapeutic endoscopic retrograde cholangiopancreatography(ERCP). Methods The clinical datas of 4 810 cases of therapeutic ERCP performed in our center from May 2003 to December 2008 were analyzed retrospectively. Results Among the 4 810 cases of ERCP,245 cases were accompanied with complications,including 113 cases of acute pancreatitis,76 cases of acute cholangitis,33 cases of alimentary tract hemorrhage;1 death from multiple organ failure caused by duodenum perforation after EST,and 1 death from acute cholangiolitis accompanied by liver function failure.The mortality and the occurrence rate of complications after therapeutic ERCP was 0.04% and 5.2%,respectively. Conclusions Strictly adhering to the indications and contraindications of ERCP and EST,skillful manipulation,adequate drainage of biliary tract and close observation of changes in patients′candition after ERCP,could diminish the complications and improve the safety of therapeutic ERCP.
出处 《中国普通外科杂志》 CAS CSCD 北大核心 2011年第3期245-248,共4页 China Journal of General Surgery
关键词 胰胆管造影术 内窥镜逆行/副作用 并发症/预防与控制 Cholangiopancreatography Endoscopic Retrograde/adv eff Complications/prev
  • 相关文献

参考文献17

  • 1Masci E, Toti G, Mariani A, et al. Complications of diag- nostic and therapeutic ERCP: a prospective muhicenter study [J]. Am J Gastroenterol, 2001 , 96(2) :417 -423.
  • 2Freeman ML, DiSario JA, Nelson DB , et al. Risk factors tbr post-ERCP pancreatitis : a prospective, multicenter study [J].Gastrointest Endosc, 2001 ,54 (4) :425 -434.
  • 3Johnson GK, Geenen JE, Johnson JF, et al. Evaluation of post-ERCP pancreatitis: potential causes noted during controlled study of differing contrast media. Midwest Pancreaticobiliary Study Group [ J ] . Gastrointest Endosc, 1997 , 46 (3) :217 -222.
  • 4Singh P, Das A, Isenberg G, et al. Does prophylactic pancreatic stent placement reduce the risk of post-ERCP acute pancreatitis .9 A meta-analysis of controlled trials [ J ]. Gastrointest Endosc, 2004,60 (4) :544 - 550.
  • 5Arvanitidis D, Anagnostopoulos GK, Giannopoulos D, et al. Can somatostatin prevent post-ERCP pancrcatitis ? Results of a randomized controlled trial [ J ]. J Gastroenterol Hepatol, 2004, 19(3) :278 -282.
  • 6Masci E, Cavallini G, Mariani A. Comparison of two dosing regimens of gabexate in the prophylaxis of post- ERCP pancreatitis[J]. Am J Gastroenterol, 2003, 98 (10):2182- 2186.
  • 7宋丽亚,赵清喜,孔心涓,田字彬,张琪.ENBD预防胆管多发结石ERCP术后急性胰腺炎及高淀粉酶血症65例[J].世界华人消化杂志,2010,18(16):1724-1727. 被引量:58
  • 8Das A, Singh P, Sivak MV JR, et al. Pancreatic-stent placement for prevention of post-ERCP pancreatitis : a cost-effectiveness analysis [ J ] . Gastrointest Endosc, 2007, 65 (7) : 960-968.
  • 9Cennamo V, Fuccio L, Zagari RM, et al. Can early precut implementation reduce endoscopic retrograde cholangiopancre- atography-related complication risk? Meta-analysis of random- ized controlled trials [ J ] . Endoscopy, 2010 , 42 ( 5 ) : 381 -388.
  • 10Petrov MS, Savides TJ. Systematic review of endoscopic ultra- sonography versus endoscopic retrograde cholangiopancreatogra- phy for suspected choledocholithiasis [ J ] . Br J Surg, 2009 , 96(9) :967 -974.

二级参考文献45

共引文献278

同被引文献300

引证文献32

二级引证文献181

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部